TCL Archive Tasigna Shows Benefit Over Gleevec In Phase III Study for Ph+ CML In Chronic Phase December 31, 2010
TCL Archive Phase III Trial Finds Cabazitaxel Increases Survival Of Advanced Prostate Cancer March 26, 2010